A recent article compares Novo Nordisk A/S with other profitable pharmaceutical stocks. The pharmaceutical industry is rapidly growing, driven by innovation and new challenges. With a compound annual growth rate of 7.63%, the industry is valued at $516.48 billion in 2022.